Univest
Univest
  • Markets

Suven Life Sciences (SUVEN) Share Price Falls 5.15% as Mid Cap Trades at Rs 290

  • October 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Suven Life Sciences Share Price
Suven Life Sciences (SUVEN) share price fell to Rs 290 today, down 5.15% from the previous close. Market cap was Rs 8,741.08 crore.

Suven Life Sciences Share Price fell 5.15% today and last traded at Rs 290, with market capitalisation at Rs 8,741.08 crore. The move took Suven Life Sciences Share Price below the previous close of Rs 305.75 and placed Suven Life Sciences in the Mid Cap category for company-size context. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes Suven Life Sciences Share Price relevant as a price-action event first, and a fundamentals-led stock analysis next. For readers tracking Suven Life Sciences Share Price Today, the combination of a decline, a low day range and a premium valuation profile against the sector backdrop is the key context. Univest data also shows that Suven Life Sciences Stock News today is about the move itself, not a fresh operational disclosure.

Table of Contents

Toggle
  • Suven Life Sciences (SUVEN) Share Price Today: Price Action Analysis
  • Suven Life Sciences (SUVEN) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Suven Life Sciences
  • About Suven Life Sciences
  • Track Suven Life Sciences Share Price on Univest
  • Frequently Asked Questions
    • Why is Suven Life Sciences Share Price falling today?
    • What is Suven Life Sciences Share Price today?
    • What does Suven Life Sciences Share Price show about intraday movement?
    • Is Suven Life Sciences a Mid Cap company?
    • How does Suven Life Sciences Share Price compare with sector valuation?
    • What do Suven Life Sciences ROE and ROCE indicate?
    • What is the book value and EPS for Suven Life Sciences?
    • Does Suven Life Sciences pay a dividend?
    • Should investors track Suven Life Sciences Share Price on Univest?

Suven Life Sciences (SUVEN) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 290
Previous Close Rs 305.75
Today's Move -Rs 15.75 (-5.15%)
Open Rs 308.75
High Rs 308.75
Low Rs 288.5
Market Capitalisation Rs 8,741.08 crore
Market Cap Category Mid Cap

Suven Life Sciences Share Price Today showed a clear intraday down move. The stock opened at Rs 308.75, matched the day’s high at Rs 308.75, touched a low of Rs 288.5 and last traded at Rs 290. The day change was Rs -15.75, which translates into a 5.15% decline from the previous close of Rs 305.75. Market capitalisation stood at Rs 8,741.For Suven Life Sciences Share Price watchers, the price action shows a gap between the opening level and the later trade, but the facts on their own do not establish a cause. As of 08 October 2026 at 12:52:50 PM IST, Suven Life Sciences Share Price was trading near the lower end of the day’s range, so the next natural step is to read the valuation and operating ratios alongside the move.

Suven Life Sciences (SUVEN) Fundamental Analysis

Metric Value
Market Capitalisation Rs 8,741.08 crore
P/B Ratio 15.51x
ROE -101.8%
ROCE -78.71%
EPS Rs -12.47
Book Value Per Share Rs 19.71
Dividend Yield 0%

Suven Life Sciences (SUVEN) fundamental metrics show P/B 15.51x, ROE -101.8%, ROCE -78.71%. These ratios show where the company stands today and are not a call to buy or sell.

Suven Life Sciences has a market capitalisation of Rs 8,741.08 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 15.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -101.8% and ROCE of -78.71%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -12.47, book value per share of Rs 19.71, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Benchmark Median P/E 31.87x
Benchmark Average P/E 48.48x
Benchmark P/E Range 3.58x to 708.87x
Company P/B Ratio 15.51x
Benchmark Median P/B 2.98x
Benchmark Average P/B 4.31x
Company ROE -101.8%
Benchmark Median ROE 11.61%
Benchmark Average ROE 10.59%
Company ROCE -78.71%
Benchmark Median ROCE 13.46%
Benchmark Average ROCE 13.36%
Company Market Capitalisation Rs 8,741.08 crore
Benchmark Median Market Cap Rs 854.81 crore
Benchmark Average Market Cap Rs 14,121.7 crore

Suven Life Sciences (SUVEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Suven Life Sciences (SUVEN) has a ROE of -101.8%, which is below the benchmark median of 11.61%, a difference of -976.83%. Suven Life Sciences (SUVEN) has a ROCE of -78.71%, which is below the benchmark median of 13.46%, a difference of -684.77%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,32,120.23 35.37 4.95 14.85 19.11
Divi's Laboratories DIVISLAB 2,53,389.76 86.95 14.4 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,81,739.76 82.14 19.96 26.76 19.27
Zydus Lifesciences ZYDUSLIFE 1,15,710.44 25.51 4.27 19.69 21.39
Laurus Labs LAURUSLABS 1,10,980.13 101.55 19.69 18.31 18.2

Its ROE of -101.8% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at -78.71% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Suven Life Sciences (SUVEN) has a market capitalisation of Rs 8,741.08 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Suven Life Sciences

  • Suven Life Sciences Share Price fell 5.15% today, with the stock last traded at Rs 290.
  • Suven Life Sciences Share Price sits near the lower end of the day’s range after opening at Rs 308.75.
  • Suven Life Sciences Fundamental Analysis shows P/B at 15.51, far above the same-industry median.
  • ROE at -101.8% and ROCE at -78.71% keep the profitability picture under review in Suven Life Sciences Stock News.
  • Suven Life Sciences Market Cap of Rs 8,741.08 crore places it in the Mid Cap category and above the industry market-cap median.

About Suven Life Sciences

Suven Life Sciences operates in Healthcare, specifically in Pharmaceuticals & Drugs. Suven Life Sciences Share Price is therefore tied to a business that sits inside a regulated and research-intensive industry, where valuation and profitability metrics often matter as much as the daily price move. The company is identified within the Mid Cap category on the company-size context. In the current Suven Life Sciences Company News frame, the most relevant facts are the sector, industry and market-cap placement rather than any unsupported narrative. Suven Life Sciences Share News today is centered on price performance, while the underlying business context remains anchored to pharmaceuticals and drugs within healthcare.

Track Suven Life Sciences Share Price on Univest

Use Suven Life Sciences (SUVEN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Track Suven Life Sciences Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights in one place. Univest also helps readers follow Suven Life Sciences Share Price Today alongside sector comparison, fundamental analysis and company context. If you are monitoring Suven Life Sciences Stock News or Suven Life Sciences Latest News, keeping the share price and key ratios together can help organise the day’s market update.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Suven Life Sciences Share Price falling today?

Ans. Suven Life Sciences Share Price fell 5.15% and last traded at Rs 290. The price move is confirmed in Univest data; a company-specific reason has not been established. The move is therefore best read as a verified price-action event.

What is Suven Life Sciences Share Price today?

Ans. Suven Life Sciences Share Price today was Rs 290. The stock was down Rs 15.75 from the previous close of Rs 305.75, and the day’s range ran from Rs 288.5 to Rs 308.75 during the ongoing session.

What does Suven Life Sciences Share Price show about intraday movement?

Ans. Suven Life Sciences Share Price opened at Rs 308.75, matched the day’s high, and later touched Rs 288.5. That range shows a clear decline from the opening level to the last traded price within the same session.

Is Suven Life Sciences a Mid Cap company?

Ans. Yes. Suven Life Sciences is marked as a Mid Cap company in the company-size context. Its market capitalisation stands at Rs 8,741.08 crore, which is above the same-industry median but below the same-industry average.

How does Suven Life Sciences Share Price compare with sector valuation?

Ans. Suven Life Sciences Share Price is linked to a P/B of 15.51, which is far above the same-industry median of 2.98 and average of 4.31. That makes valuation an important part of the current stock discussion.

What do Suven Life Sciences ROE and ROCE indicate?

Ans. Suven Life Sciences reports ROE of -101.8% and ROCE of -78.71%. Both are below the same-industry medians and averages, so the profitability and capital-return profile remains a key point in Suven Life Sciences Share Price analysis.

What is the book value and EPS for Suven Life Sciences?

Ans. Suven Life Sciences Share Price sits alongside EPS of -12.47 and book value of Rs 19.71. EPS shows earnings attributable to each share, while book value shows accounting net worth behind each share at the current time.

Does Suven Life Sciences pay a dividend?

Ans. The dividend yield is 0%, so Suven Life Sciences Share Price is not accompanied by a current payout yield in the latest Univest figures. That keeps the focus on price action, valuation and profitability rather than income yield.

Should investors track Suven Life Sciences Share Price on Univest?

Ans. Yes. Univest gives a single view of Suven Life Sciences Share Price, valuation ratios, sector context and peer comparison. That makes it easier to follow price movement, fundamental analysis and stock news without losing the broader market setting.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply